On September 20, 2024, Aion Therapeutic Inc. (CSE: AION) announced the successful closure of the first tranche of its non-brokered private placement offering. The company issued 22,000,000 units at a price of $0.011 per unit, resulting in total gross proceeds of $242,000. Each unit comprises one common share and one half of one common share purchase warrant. The warrants are exercisable to acquire one share for a period of eighteen months post the offering’s closure at an exercise price of $0.05 per warrant share.
The proceeds from the offering will be utilized for general working capital purposes. All securities issued will be subject to a hold period of four months and one day as stipulated by applicable securities laws. It is important to note that this news release does not constitute an offer to sell or a solicitation of an offer to buy any securities. Additionally, the securities issued have not been registered under the United States Securities Act of 1933 or state securities laws and may not be offered or sold within the United States or to U.S. Persons unless under an exemption and in compliance with applicable laws.
Aion Therapeutic Inc. is a progressive player in the health and wellness sector with a diverse intellectual property portfolio. Through innovation and transformative solutions, the company aims to push the boundaries of health and wellness. Its subsidiary, Toppen, is dedicated to delivering cutting-edge water filtration solutions that prioritize innovation, affordability, and sustainability to meet various consumer, business, and industrial water needs globally.
For more information, please refer to the disclaimer and reader advisory section within this release. It is important to note that forward-looking information in this release involves risks and uncertainties that may cause actual results to differ from expressed or implied forward-looking information. The company assumes no obligation to update such information unless required by applicable securities legislation. The Canadian Securities Exchange has not endorsed the contents of this press release.
This content is not intended for distribution to United States newswire services or dissemination in the United States. To view the original press release, kindly visit the source version link provided.
